1 2 3 4 5

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

Potkin, Steven G.; Loze, Jean-Yves; Forray, Carlos; More

International Clinical Psychopharmacology . 32(3):147-154, May 2017.

A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major...

Higuchi, Teruhiko; Kamijima, Kunitoshi; Nakagome, Kazuyuki; More

International Clinical Psychopharmacology . 31(1):8-19, January 2016.

Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study

Rolland, Benjamin; Valin, Thomas; Langlois, Carole; More

International Clinical Psychopharmacology . 30(1):49-53, January 2015.

Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics

Kwon, Jun Soo; Kim, Sung Nyun; Han, Jaewook; More

International Clinical Psychopharmacology . 30(6):320-328, November 2015.

Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study

Clayton, Anita H.; Durgam, Suresh; Li, Dayong; More

International Clinical Psychopharmacology . 32(1):27-35, January 2017.

Serum concentrations of psychotropic drugs in neonates as a PROgnOstic Factor for admission to the neonatology ward and withdrawal symptoms: PROOF-1

Sparla, Shirley C.A.; Coppens, Hans; Evers, Inge M.; More

International Clinical Psychopharmacology . 32(3):142-146, May 2017.

1 2 3 4 5